Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dolores Fraga

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 24, 2025
[Translated article] The relevance of therapeutic positioning in the post-approval evaluation of new drugsEmilio Jesús Alegre-Del Rey, Silvia Fénix-Caballero, María Dolores Fraga Fuentes, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 20, 2024
The relevance of therapeutic positioning in the post-approval evaluation of new medicinesEmilio Jesús Alegre-Del Rey, Silvia Fénix-Caballero, María Dolores Fraga Fuentes, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 8, 2015
[Off-label use of oncology drugs: national survey results]Eva González-Haba Peña, María José Agustín Ferrández, Irene Mangues Bafalluy, et al.
Journal of Clinical Pharmacy and Therapeutics|December 20, 2019
Checklist for clinical applicability of subgroup analysisManuel David Gil-Sierra, Silvia Fénix-Caballero, Laila Abdel Kader-Martin, et al.
Diabetes & Metabolic Syndrome|October 23, 2025
Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective studyJosé Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Dominguez, et al.
Clinical Therapeutics|May 8, 2026
Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study)José Seijas-Amigo, Ángel Salgado-Barreira, Carlota Roca-Martinez, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 24, 2025
[Translated article] The relevance of therapeutic positioning in the post-approval evaluation of new drugsEmilio Jesús Alegre-Del Rey, Silvia Fénix-Caballero, María Dolores Fraga Fuentes, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 20, 2024
The relevance of therapeutic positioning in the post-approval evaluation of new medicinesEmilio Jesús Alegre-Del Rey, Silvia Fénix-Caballero, María Dolores Fraga Fuentes, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 8, 2015
[Off-label use of oncology drugs: national survey results]Eva González-Haba Peña, María José Agustín Ferrández, Irene Mangues Bafalluy, et al.
Journal of Clinical Pharmacy and Therapeutics|December 20, 2019
Checklist for clinical applicability of subgroup analysisManuel David Gil-Sierra, Silvia Fénix-Caballero, Laila Abdel Kader-Martin, et al.
Diabetes & Metabolic Syndrome|October 23, 2025
Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective studyJosé Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Dominguez, et al.
Clinical Therapeutics|May 8, 2026
Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study)José Seijas-Amigo, Ángel Salgado-Barreira, Carlota Roca-Martinez, et al.
Pageof 2